Header Logo

Connection

JAFFER A AJANI to Receptors, Vascular Endothelial Growth Factor

Back to Details
This is a "connection" page, showing publications JAFFER A AJANI has written about Receptors, Vascular Endothelial Growth Factor.
JAFFER A AJANI
Connection Strength
0.839
Receptors, Vascular Endothelial Growth Factor
  1. Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies. Oncology. 2016; 90(1):10-20.
    View in: PubMed
    Score: 0.461
  2. Targeting Angiogenesis in Colorectal Carcinoma. Drugs. 2019 Jan; 79(1):63-74.
    View in: PubMed
    Score: 0.144
  3. Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab. Br J Cancer. 2016 10 11; 115(8):974-982.
    View in: PubMed
    Score: 0.123
  4. Molecular biomarkers in gastric cancer. J Natl Compr Canc Netw. 2015 Apr; 13(4):e19-29.
    View in: PubMed
    Score: 0.111
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.